TVRD 424B5: Secondary offering
Tvardi Therapeutics
Filed with the SEC on · accession 0001104659-26-084619
TVRD filed a 424B5 (prospectus (offering)) with the SEC on Jul 17, 2026. The final terms of an offering of shares or bonds. The stock moved +3.9% by the first close after the filing.
Summary of the filing
Tvardi Therapeutics filed a prospectus supplement to offer up to $9,689,765 of common stock in an at-the-market offering through JonesTrading, following prior sales of $11.0 million under the same agreement.
Key details
How TVRD stock reacted
Close before
$3.08
Jul 16, 2026
First close after
+3.90%
$3.20
5 trading days
-16.88%
$2.56
Since filing
-63.96%
$1.11
✦ Ask GOAX AI about this filing — what it means for TVRD, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TVRD?
Click hereFrequently asked questions
What did TVRD file with the SEC on Jul 17, 2026?
TVRD filed a 424B5 (Secondary offering). Tvardi Therapeutics filed a prospectus supplement to offer up to $9,689,765 of common stock in an at-the-market offering through JonesTrading, following prior sales of $11.0 million under the same agreement.
What does a secondary offering mean for TVRD stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did TVRD stock react to this filing?
TVRD closed at $3.08 before the filing and $3.20 on Jul 17, 2026 (+3.90%). Five trading days later: $2.56 (-16.88%).
Other TVRD SEC filings
Get alerts when TVRD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days